Live news related to EXOSENS stock (FR001400Q9V2): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on EXOSENS mainly cover M&A activity et share price moves. The stock trades at €62,10 on Euronext Paris, up 1,14% at the last update. This page lists the articles published on EXOSENS stock to track the share price, company announcements and any item likely to influence market perception.
The French imaging technology specialist released a technical article on July 22 comparing cooled and uncooled infrared camera approaches, aimed at di…
The French specialist in night vision and imaging technologies for defense significantly recovers in mid-morning trading. The stock climbs to the top …
Exosens has released a scientific study showcasing a femtosecond laser-based method for fabricating optical nanostructures, demonstrating the capabili…
The French specialist in night vision and imaging technologies for defense significantly rebounds in mid-morning trading. The stock is recovering from…
The French night vision technology specialist regains momentum in mid-morning trading, driven by the announcement of a long-term agreement with the Cz…
Exosens signed a multi-year agreement with Brolis on Monday to supply the Czech armed forces with image intensifier tubes. This order, the largest eve…
The French specialist in night vision and imaging technology for defense continues its slide in mid-morning trading. The stock is at the bottom of the…
The French specialist in night vision and imaging technologies for defense continues its downturn in mid-afternoon trading. The stock breaks a new tec…
French specialist in night vision and imaging technologies for defense announced on Thursday that it has secured a €140 million credit facility from t…
On Wednesday, Exosens announced the launch of PhaseStudio, a software developed over four years aimed at revolutionizing wavefront measurement in opti…
